ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,318.54
0.20%
US Tech 100
18,125.56
0.05%
다우존스 지수
39,996.50
0.22%
Bitcoin
65,866.24
-0.59%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Stoke Therapeutics Inc (STOK)

  7. Stoke Therapeutics Inc (STOK) 뉴스

STOK Stoke Therapeutics Inc

14.25
0.12 (0.85%)
최종 업데이트: 23:09:09
15분 지연
기업명 주식 심볼 시장 주식 타입
Stoke Therapeutics Inc STOK 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.12 0.85% 14.25 23:09:09
개장가 저가 고가 종가 전일 종가
14.15 13.91 14.2899 14.13
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
07/05/202405:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/05/202420:05EDGAR2Form 8-K - Current report
06/05/202420:00BWStoke Therapeutics Reports First Quarter Financial Results..
29/04/202421:00BWStoke Therapeutics Appoints Thomas Leggett as Chief..
17/04/202421:00BWStoke Therapeutics Appoints Jason Hoitt as Chief Commercial..
05/04/202405:30BWStoke Therapeutics to Present at the 23rd Annual Needham..
28/03/202412:40BWStoke Therapeutics Announces Pricing of Upsized $125 Million..
27/03/202405:07BWStoke Therapeutics Announces Proposed Public Offering
26/03/202405:01BWStoke Therapeutics Announces Landmark New Data That Support..
06/03/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:28EDGAR2Form 144 - Report of proposed sale of securities
27/02/202400:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/02/202400:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202423:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202406:49EDGAR2Form 144 - Report of proposed sale of securities
18/01/202406:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
08/01/202422:09EDGAR2Form 8-K - Current report
08/01/202422:00BWStoke Therapeutics Highlights Strategic Priorities and..
05/01/202406:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:30BWStoke Therapeutics to Present at the 42nd Annual J.P. Morgan..
03/01/202406:29EDGAR2Form 144 - Report of proposed sale of securities
15/12/202306:05EDGAR2Form 8-K - Current report
06/12/202306:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202306:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202306:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202306:08EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
01/12/202323:04EDGAR2Form 8-K - Current report
01/12/202323:00BWStoke Therapeutics Presents Data From Multiple Studies of..
21/11/202322:00BWStoke Therapeutics to Present Data from the Company’s Dravet..
18/11/202306:37EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
10/11/202306:28EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
08/11/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:05EDGAR2Form 8-K - Current report
07/11/202321:00BWStoke Therapeutics Reports Third Quarter Financial Results..
07/11/202306:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/11/202322:01EDGAR2Form SC TO-I - Tender offer statement by Issuer
27/10/202306:00EDGAR2Form 8-K - Current report
18/10/202305:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
29/09/202305:05EDGAR2Form DEF 14A - Other definitive proxy statements
21/09/202321:00BWStoke Therapeutics to Participate in the 2023 Cantor Global..
21/09/202305:37EDGAR2Form 8-K - Current report
21/09/202305:30BWStoke Therapeutics Appoints Ian Smith to its Board of..
19/09/202305:05EDGAR2Form PRE 14A - Other preliminary proxy statements
05/09/202320:00BWStoke Therapeutics Presents Data Related to the Ongoing..
08/08/202305:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/08/202320:05EDGAR2Form 8-K - Current report
07/08/202320:00BWStoke Therapeutics Reports Second Quarter Financial Results..
02/08/202321:00BWStoke Therapeutics to Present at the Canaccord Genuity 43rd..
25/07/202320:05EDGAR2Form 8-K - Current report

최근 히스토리

NASDAQ
STOK
Stoke Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유